Pharmaceutical company GSK's RSV vaccine has been approved by the US Food and Drug Administration (FDA) to become the world's first such vaccine. Known as Arexvy, this vaccine has been approved after three clinical trials.
As per a report in Nature, the vaccine has been approved for use in people above 60 years.
